Materialien

Laden Sie unsere kostenlosen Informationsmaterialien herunter, um mehr über Zelltherapie, Vermarktung und Herstellung zu erfahren, und wie Minaris Regenerative Medicine Ihre Therapie voranbringen kann. Wir werden hier in naher Zukunft weitere wertvolle Inhalte hinzufügen.

brochure

Large-Scale Cell Therapy Manufacturing Using 3D Bioreactors - A Cost-Effective Approach

To make cell therapies widely available, efficient manufacturing process for large quantities of living human stem cells are needed. At Minaris, our team of experts have developed efficient large-scale cell product processes utilizing 3D bioreactors to expand adherent and non-adherent cells.

white papers

Creating Cell Therapy Solutions

Minaris' global team of experts have become a trusted partner for clinical and commercial manufacturing of cell therapies. Download our feature that is seen within Nature Biopharma Dealmakers September 2021 issue to read more about our manufacturing, consulting, and development services, and how we are delivering cell-based therapies to patients globally.

white paper

The Commercial Manufacturing Checklist for Cell Therapy Developers

To determine whether your patient-specific cell therapy product is ready for commercially viable manufacturing, our team has put together a checklist of items meant to provide you with a rough idea of where your process stands and your commercial readiness.

white paper

A Place for NK Cells in the Journey Towards the Next Generation of Adoptive Immunotherapies

In this brief overview, our experts discuss several ways in which Natural Killer (NK) cells can offer us a path forward as a deliver platform for engineered cell (and ex vivo gene) therapy. Here, we focus on four different aspects of cytotoxic cell therapy and provide some contrasts where we feel NK cells can offer promise: Durability, Control, Manufacturing, and Toxicity.

white paper

Impact of Apheresis Collection Quality on Manufacturing of Cell Therapeutics

With cell therapy pipelines growing rapidly each year, the need for optimized apheresis collections, a critical first step in the manufacture of many cell therapy products, is evident. Highly variable or poor quality starting apheresis collections present a significant engineering and manufacturing development challenge.

white paper

The Cold Truth: Cryopreservation of Final Product in Cell Therapy Manufacturing

While using “fresh” final products in cell therapy manufacturing is perfectly acceptable for proof of concept of the cell therapy, as development into late-stage and then commercial production becomes the goal, different constraints arise. This is where cryopreservation of the final product becomes an option and, in some cases, even a necessity.

brochure

Minaris Regenerative Medicine Company Brochure

Minaris Regenerative Medicine is a global contract and manufacturing organization (CDMO) for cell and gene therapies. We offer our clients high value clinical and commercial manufacturing service, development solutions, and technologies. We are pioneers in the field with more than 20 years' experience providing outstanding quality and reliability.

brochure

EU Import and QP Batch Certification of Cell and Gene Therapies

As a full service Contract Development and Manufacturing Organisation (CDMO), Minaris Regenerative Medicine offers EU import services and QP batch certification for cell and gene therapy products manufactured outside the European Union. Our team of experienced Qualified Persons at our manufacturing facilities in Germany is ready to help you to enter the European market.

white papers

Risk Assessment of SARS-CoV-2 propagation

Early in the COVID-19 Pandemic, our scientists and engineers were asked about whether SARS-CoV-2, the virus that causes COVID-19, posed risk to patients through the manufactured cell therapies they receive. The journal Regenerative Medicine has published a paper written in collaboration between our Germany process development team and our colleagues at Minaris USA - "A risk assessment study of SARS-CoV-2 propagation in the manufacturing of cellular products".

Materialien

Suche Nach Typ:

Alle

Large-Scale Cell Therapy Manufacturing Using 3D Bioreactors - A Cost-Effective Approach

Creating Cell Therapy Solutions

The Commercial Manufacturing Checklist for Cell Therapy Developers

A Place for NK Cells in the Journey Towards the Next Generation of Adoptive Immunotherapies

Impact of Apheresis Collection Quality on Manufacturing of Cell Therapeutics

The Cold Truth: Cryopreservation of Final Product in Cell Therapy Manufacturing

Minaris Regenerative Medicine Company Brochure

EU Import and QP Batch Certification of Cell and Gene Therapies

Risk Assessment of SARS-CoV-2 propagation

Für unseren E-Mail-Verteiler anmelden